1. Home
  2. NKGN vs KSCP Comparison

NKGN vs KSCP Comparison

Compare NKGN & KSCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKGN
  • KSCP
  • Stock Information
  • Founded
  • NKGN 2017
  • KSCP 2013
  • Country
  • NKGN United States
  • KSCP United States
  • Employees
  • NKGN N/A
  • KSCP N/A
  • Industry
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • KSCP Telecommunications Equipment
  • Sector
  • NKGN Health Care
  • KSCP Telecommunications
  • Exchange
  • NKGN Nasdaq
  • KSCP Nasdaq
  • Market Cap
  • NKGN 8.1M
  • KSCP 40.9M
  • IPO Year
  • NKGN N/A
  • KSCP 2022
  • Fundamental
  • Price
  • NKGN $0.42
  • KSCP $15.75
  • Analyst Decision
  • NKGN
  • KSCP Strong Buy
  • Analyst Count
  • NKGN 0
  • KSCP 1
  • Target Price
  • NKGN N/A
  • KSCP $200.00
  • AVG Volume (30 Days)
  • NKGN 2.6M
  • KSCP 378.2K
  • Earning Date
  • NKGN 11-12-2024
  • KSCP 11-11-2024
  • Dividend Yield
  • NKGN N/A
  • KSCP N/A
  • EPS Growth
  • NKGN N/A
  • KSCP N/A
  • EPS
  • NKGN N/A
  • KSCP N/A
  • Revenue
  • NKGN N/A
  • KSCP $11,794,000.00
  • Revenue This Year
  • NKGN N/A
  • KSCP N/A
  • Revenue Next Year
  • NKGN N/A
  • KSCP $41.67
  • P/E Ratio
  • NKGN N/A
  • KSCP N/A
  • Revenue Growth
  • NKGN N/A
  • KSCP 16.70
  • 52 Week Low
  • NKGN $0.20
  • KSCP $4.89
  • 52 Week High
  • NKGN $5.10
  • KSCP $42.50
  • Technical
  • Relative Strength Index (RSI)
  • NKGN 48.24
  • KSCP 78.91
  • Support Level
  • NKGN $0.20
  • KSCP $6.71
  • Resistance Level
  • NKGN $0.65
  • KSCP $20.46
  • Average True Range (ATR)
  • NKGN 0.11
  • KSCP 1.77
  • MACD
  • NKGN 0.03
  • KSCP 1.11
  • Stochastic Oscillator
  • NKGN 31.78
  • KSCP 68.90

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

About KSCP Knightscope Inc.

Knightscope Inc is an advanced security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

Share on Social Networks: